According to Articles 34 and 35 of Chinese Patent Law, an invention patent application (versus a utility model or a design patent application) will be published within 18 months from its filing date (or earliest claimed priority date) after passing …
Category: China
Are You Ready for China’s Patent Linkage System?
On September 11, 2020, the National Medical Products Administration (NMPA) and the China National Intellectual Property Administration (CNIPA) issued the “Implementing Measures for Drug Patent Dispute Early Resolution Mechanism (Trial for Implementation)” (Draft Measures). The Draft Measures establish a framework …
Read More "Are You Ready for China’s Patent Linkage System?"
Filing Divisional Patent Applications in China – Part 3
This is the third post in our 16-part series examining divisional practice in Argentina, Brazil, Canada, China, Europe, India, Indonesia, Malaysia, Mexico, Pakistan, Russia, Thailand, Saudi Arabia, Singapore, the United States, Vietnam (in no particular order). Our first two posts …
Read More "Filing Divisional Patent Applications in China – Part 3"
USTR 2018 Special 301 Report – Priority Watch List Country – China
In April, the Office of the United States Trade Representative (USTR) released its 2018 Special 301 Report (the Report) identifying trading partners that do not adequately or effectively protect and enforce intellectual property (IP) rights or otherwise deny market access …
Read More "USTR 2018 Special 301 Report – Priority Watch List Country – China"
USTR 2018 Special 301 Report: Pharmaceutical and Medical Device Innovation and Market Access
Last month, the Office of the United States Trade Representative (USTR) released its 2018 Special 301 Report (the Report), identifying trading partners that do not adequately or effectively protect and enforce intellectual property (IP) rights or otherwise deny market access …